Evaluation of in vitro assays (lymphocyte proliferation assays, cytokine production assays and/or T spot TBtm and/or Quantiferon-TB Gold) during follow-up of individuals with recent Mantoux skin test conversion, or (latent or clinically active) Tuberculosis.

Evaluation of in vitro assays (lymphocyte proliferation assays, cytokine production assays and/or T spot TBtm and/or Quantiferon-TB Gold) during follow-up of individuals with recent Mantoux skin test conversion, or (latent or clinically active) Tuberculosis. - C09/ad

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON31206

Enrollment

300

Registered

2007-07-16

Start date

2007-04-17

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prevention Tuberculosis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age at least 18 Years at time of entry into the study. Positive TST result during a contact investigation, or being (have been) treated for latent or active tuberculosis. Written informed consent.

Exclusion criteria

Exclusion criteria: nvt

Design outcomes

Primary

Measure	Time frame
nvt	—

Secondary

Measure	Time frame
T Spot TB and Quantiferon-TB Gold.	—

Countries

Netherlands

Outcome results